Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Breast Neoplasms 3Neoplasms 2Fatigue 2Weight Loss 1Systemic carnitine deficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Neurotoxicity Syndromes 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Malnutrition 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Hyperbilirubinemia 1Hyperandrogenism 1Hirsutism 1Heart Failure 1Gastrointestinal Stromal Tumors 1Dyslipidemias 1Depression 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Cachexia 1Burkitt Lymphoma 1Basal Cell Nevus Syndrome 1

Interventions

Creatine 2telitacicept 1nicotinamide-beta-riboside 1fludarabine 1Testosterone 1Positron-Emission Tomography 1Magnetic Resonance Imaging 1Exercise Movement Techniques 1Eicosapentaenoic Acid 1Cyclophosphamide 1Carnitine 1Caloric Restriction 1Autogenic Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Muscle Weakness × Carnitine × Clear all
NCT03151291 2018-10-16

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
200 enrolled

Motor Activity, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡